Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

[Liver biopsy studies in long-term therapy of psoriasis using methotrexate].

Dietz O, Pachaly A, Schillat I.

Dermatol Monatsschr. 1974 Aug;160(8):634-42. German. No abstract available.

PMID:
4216519
2.

Hepatotoxicity of methotrexate in the treatment of psoriasis.

Palmer HM.

Practitioner. 1973 Sep;211(263):324-8. No abstract available.

PMID:
4759241
3.

Hepatotoxicity of long-term methotrexate therapy for psoriasis.

Tobias H, Auerbach R.

Arch Intern Med. 1973 Sep;132(3):391-6. No abstract available.

PMID:
4783020
4.

Ultrasound as a screening procedure for methotrexate-induced hepatic damage in severe psoriasis.

Miller JA, Dodd H, Rustin MH, Lees WR, Levene GM, Kirby JD, Munro DD.

Br J Dermatol. 1985 Dec;113(6):699-705.

PMID:
3913457
5.

Methotrexate maintenance therapy and liver damage in psoriasis.

van de Kerkhof PC, Hoefnagels WH, van Haelst UJ, Mali JW.

Clin Exp Dermatol. 1985 May;10(3):194-200. No abstract available.

PMID:
4006282
6.

Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.

Hendel J, Poulsen H, Nyfors B, Nyfors A.

Acta Pharmacol Toxicol (Copenh). 1985 Apr;56(4):321-6.

PMID:
4024960
7.

Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis.

Geronemus RG, Auerbach R, Tobias H.

Arch Dermatol. 1982 Sep;118(9):649-51.

PMID:
7114866
8.

Liver disease in psoriatics--An effect of methotrexate therapy?

Shapiro HA, Trowbridge JO, Lee JC, Maibach HI.

Arch Dermatol. 1974 Oct;110(4):547-51. No abstract available.

PMID:
4414499
9.

Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy.

Lawrence CM, Strange RC, Summerly R, Scriven AJ, Elmahallawy M, Wood A, Fletcher PJ, Beckett GJ.

Clin Chim Acta. 1983 Apr 25;129(3):341-51.

PMID:
6851172
10.

[Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].

Moldenhauer E, Dabels J, Diwok K, Leithäuser W, Nowotny P.

Dermatol Monatsschr. 1973 Mar;159(3):242-8. German. No abstract available.

PMID:
4704945
11.

Liver biopsy in methotrexate treatment.

Zachariae H, Schiodt T.

Acta Derm Venereol. 1971;51(3):215-20. No abstract available.

PMID:
4103033
12.

Methotrexate induced liver disease in psoriasis.

Millward-Sadler GH, Ryan TJ.

Br J Dermatol. 1974 Jun;90(6):661-7. No abstract available.

PMID:
4853200
13.

Liver injury associated with methotrexate therapy for psoriasis.

Podurgiel BJ, McGill DB, Ludwig J, Taylor WF, Muller SA.

Mayo Clin Proc. 1973 Nov;48(11):787-92. No abstract available.

PMID:
4758150
14.

[Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].

Nieminen U, Höök-Nikanne J, Kärkkäinen P, Niemelä S.

Duodecim. 2005;121(24):2680-8. Review. Finnish. No abstract available.

PMID:
16454249
15.

Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.

Weinstein GD, Cox JW, Suringa DW, Millard MM, Kalser M, Frost P.

Arch Dermatol. 1970 Dec;102(6):613-8. No abstract available.

PMID:
5501902
16.

Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.

Themido R, Loureiro M, Pecegueiro M, Brandão M, Campos MC.

Acta Derm Venereol. 1992 Sep;72(5):361-4.

PMID:
1361285
17.

[Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].

Ruszczak Z, Prószyńska-Kuczyńska W, Babiński S, Biernat S, Kulig A.

Przegl Dermatol. 1974 Nov-Dec;61(6):803-7. Polish. No abstract available.

PMID:
4431967
18.

Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.

Chalmers RJ, Kirby B, Smith A, Burrows P, Little R, Horan M, Hextall JM, Smith CH, Klaber M, Rogers S.

Br J Dermatol. 2005 Mar;152(3):444-50.

PMID:
15787812
19.

Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.

Berends MA, van Oijen MG, Snoek J, van de Kerkhof PC, Drenth JP, Han van Krieken J, de Jong EM.

Arch Dermatol. 2007 Dec;143(12):1515-9.

PMID:
18087000
20.

A prospective study of the effects of weekly oral methotrexate on liver biopsy.

Warin AP, Landells JW, Levene GM, Baker H.

Br J Dermatol. 1975 Sep;93(3):321-7.

PMID:
1103936

Supplemental Content

Support Center